Merger & Acquisition

All articles by Merger & Acquisition

As 2023 midpoint nears, signs of life emerge in biopharma dealmaking
As 2023 midpoint nears, signs of life emerge in biopharma dealmaking
Marc Iskowitz
June 7, 2023
9:46 am

The year’s first six months reveal a clear appetite for biopharma M&A, although an emboldened FTC has made dealmakers wary.

Novo Nordisk enters talks to buy device maker Biocorp
Novo Nordisk enters talks to buy device maker Biocorp
Jack O'Brien
June 5, 2023
10:55 am

Novo is seeking to acquire a controlling stake in the company from majority shareholder Bio Jag for around $165 million.

Calcium+Company buys scientific comms agency CSG Health Group
Calcium+Company buys scientific comms agency CSG Health Group
Jack O'Brien
June 1, 2023
3:12 pm

Calcium+Company CEO Judy Capano said the CSG purchase marks the latest milestone in the firm’s ongoing expansion and transformation efforts.

MEI Pharma receives unsolicited takeover bid amid Infinity merger
MEI Pharma receives unsolicited takeover bid amid Infinity merger
Lecia Bushak
May 31, 2023
12:03 pm

The proposal from investors Anson Funds Management and Cable Car Capital comes after MEI Pharma already planned a merger with Infinity Pharmaceuticals.

Medtronic snaps up EOFlow for $738 million to bolster its diabetes business
Medtronic snaps up EOFlow for $738 million to bolster its diabetes business
Lecia Bushak
May 25, 2023
2:19 pm

Medtronic will acquire EOFlow, which manufactures the insulin patch pump EOPatch, to help expand its diabetes offerings.

A more aggressive FTC is starting to target drug mergers and industry middlemen
A more aggressive FTC is starting to target drug mergers and industry middlemen
Arthur Allen, KFF Health News
May 22, 2023
11:30 am

The Federal Trade Commission is moving against drug companies and industry middlemen as part of the Biden administration’s push for lower drug prices at the pharmacy counter.

FTC sues to block Amgen’s $27.8B deal for Horizon Therapeutics
FTC sues to block Amgen’s $27.8B deal for Horizon Therapeutics
Jack O'Brien
May 16, 2023
9:56 am

News of the FTC’s pending challenge to the Amgen deal sunk Horizon’s stock during early morning trading Tuesday, with the company’s shares down more than 17%.

Sobi buys CTI BioPharma in $1.7B rare disease play
Sobi buys CTI BioPharma in $1.7B rare disease play
Jack O'Brien
May 10, 2023
1:18 pm

Sobi’s acquisition is set to bolster its hematology franchise with the addition of Vonjo, a novel oral kinase inhibitor that treats myelofibrosis.

Syneos Health gets scooped up by PE firms for $7.1B
Syneos Health gets scooped up by PE firms for $7.1B
Jack O'Brien
May 10, 2023
10:05 am

The deal is expected to be completed in the second half of the year, subject to approval of Syneos Health shareholders as well as other customary closing conditions.

Gilead acquires XinThera to bolster oncology and inflammation pipeline
Gilead acquires XinThera to bolster oncology and inflammation pipeline
Lecia Bushak
May 9, 2023
1:24 pm

The acquisition gives Gilead two small molecule inhibitor programs — one in cancer and another in inflammatory diseases.

  • From Our Partners